Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Health experts dismayed by President Biden's view that the pandemic is over: 'Hell no — not even close'
04:49pm, Monday, 19'th Sep 2022 MarketWatch
Health experts reacted with dismay Monday to U.S. President Joe Biden's assertion that the pandemic is over in an interview on "60 Minutes" that aired on Sunday.
'Reshoring' is poised to boost U.S. companies bringing business back home. Shares of these 17 companies will benefit.
04:44pm, Monday, 19'th Sep 2022 MarketWatch
Automation, construction and chip companies will be the recipients of billions of dollars in capital-expenditure spending.
Merck's (MRK) Pneumococcal Jab Gets CHMP Endorsement for Kids
04:21pm, Monday, 19'th Sep 2022 Zacks Investment Research
The EMA's CHMP recommends approving Merck's (MRK) pneumococcal 15-valent conjugate vaccine for expanded use in infants and children. The vaccine received similar approval from the FDA in June 2022.
2 Biotech Stocks You Can Buy and Hold for the Next Decade
01:37pm, Monday, 19'th Sep 2022 The Motley Fool
It's hard to imagine a world in which pharmaceutical spending doesn't increase year in and year out.
Zacks Investment Ideas feature highlights: Pfizer, Apple and Alphabet
09:23am, Monday, 19'th Sep 2022 Zacks Investment Research
Pfizer, Apple and Alphabet have been highlighted in this Investment Ideas article.
2 Good-News Stocks on a Frightful Friday
10:12pm, Friday, 16'th Sep 2022 The Motley Fool
Wall Street ended a terrible week with further declines.
Pfizer's (PFE) Late-Stage Meningococcal Jab Study Meets Goal
05:41pm, Friday, 16'th Sep 2022 Zacks Investment Research
Based on positive top-line data from phase III on its pentavalent meningococcal vaccine, Pfizer (PFE) intends to submit a regulatory application to the FDA seeking approval by year-end.
Pharma Stock Roundup: J&J New Buyback Plan, CHMP Nod to PFE's BA.4, BA.5 Omicron Jab
02:39pm, Friday, 16'th Sep 2022 Zacks Investment Research
J&J (JNJ) announces a new $5 billion stock buyback plan. CHMP recommends authorizing Pfizer's (PFE) Omicron BA.4 and BA.5 boosters in Europe.
Is Trending Stock Pfizer Inc. (PFE) a Buy Now?
01:00pm, Friday, 16'th Sep 2022 Zacks Investment Research
Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.
3 Mega-Cap Stocks With Unbelievably Strong Free Cash Flow
06:35pm, Thursday, 15'th Sep 2022 Zacks Investment Research
All three companies generate substantial cash. In fact, one reported the highest quarterly free cash flow of any S&P 500 company in Q2.
Pfizer (PFE) Starts Late-Stage Study on Influenza Vaccine
03:54pm, Thursday, 15'th Sep 2022 Zacks Investment Research
Pfizer (PFE) doses the first participants in the phase III study of its investigational mRNA-based influenza vaccine. The study will enroll nearly 25,000 participants.
Zacks Market Edge Highlights: 3M, Northwest Bancshares, Pfizer, Xerox, Enterprise Products Partners
12:40pm, Thursday, 15'th Sep 2022 Zacks Investment Research
3M, Northwest Bancshares, Pfizer, Xerox, Enterprise Products Partners have been highlighted in this Market Edge article.
Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know
09:45pm, Wednesday, 14'th Sep 2022 Zacks Investment Research
Pfizer (PFE) closed the most recent trading day at $46.15, moving -0.09% from the previous trading session.
How to Have Fun Investing
07:16pm, Wednesday, 14'th Sep 2022 Zacks Investment Research
Get paid for being an owner of a business. Collect those dividend checks and watch them compound.
1 Dirt Cheap Dividend Stock to Buy Right Now
02:15pm, Wednesday, 14'th Sep 2022 The Motley Fool
Wall Street may be ignoring this drugmaker's long-term potential.
